Arg506Gln Factor V Mutation and Val34Leu Factor XIII Polymorphism in Finnish Patients with Inflammatory Bowel Disease

References

• Talbot RW, Heppell J, Dozois RR, Beart RW Jr. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986;61:140–5.
   Google Scholar
• Lake AM, Stauffer JQ, Stuart MJ. Hemostatic alterations in inflammatory bowel disease. Response to therapy. Dig Dis 1978;23:897–902.
   Google Scholar
• Edwards RL, Levine JB, Green R, Duffy M, Mathews E, Brande W, et al. Activation of blood coagulation in Crohn’s disease. Gastroenterology 1987;92:329–37.
   PubMed Web of Science ®Google Scholar
• Wisen O, Gerdlund B. Hemostasis in Crohn’s disease: low factor XIII levels in active disease. Scand J Gastroenterol 1988; 23:961–6.
   PubMed Web of Science ®Google Scholar
• Knot E, Ten Cate JW, Leeksma OC, Tytgat GN, Vreeken J. No evidence for a prethrombotic state in stable chronic inflammatory bowel disease. J Clin Pathol 1983;36:1387–90.
   PubMed Web of Science ®Google Scholar
• Seitz R, Leugner F, Katschinski M, Immel A, Kraus M, Egbring R, et al. Ulcerative colitis and Crohn’s disease: factor XIII, inflammation and hemostasis. Digestion 1994;55:361–7.
   PubMed Web of Science ®Google Scholar
• Oshitani N, Kitano A, Hara J, Suzuki N, Aoki T, Yasuda K, et al. Deficiency of blood coagulation factor XIII in Crohn’s disease. Am J Gastroenterol 1995;90:1116–8.
   PubMed Web of Science ®Google Scholar
• Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64–7.
   Google Scholar
• Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993;342:1503–6.
   PubMed Web of Science ®Google Scholar
• Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994;330:517–22.
   PubMed Web of Science ®Google Scholar
• Griffin JH, Evatt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993;82:1989–93.
   PubMed Web of Science ®Google Scholar
• Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004–8.
   Google Scholar
• Mikkola H, Syrjälä M, Rasi V, Vahtera E, Hämäläinen E, Peltonen L, et al. Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood 1994;84:517–25.
   PubMed Web of Science ®Google Scholar
• Kohler HP, Stickland MH, Ossei-Gerning N, Carter A, Mikkola H, Grant PJ. A common polymorphism in the Factor XIII gene and myocardial infarction in patients with ischaemic heart disease. Thromb Haemost 1998;79:8–13.
   Google Scholar
• Wartiovaara U, Perola M, Mikkola H, Tötterman K, Savolainen V, Perttilä A, et al. Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males. Atherosclerosis 1999;142: 295–300.
   Google Scholar
• Linna T, Ylikorkala A, Kontula K, Puska P, Tervo T. Prevalence of Factor V Leiden in young adults with retinal vein occlusion. Thromb Haemost 1997;77:214–6.
   Google Scholar
• Ihalainen J, Siitari H, Syvänen A-C, Palotie A. Towards automatic detection of point mutations: use of scintillating microplates in solid-phase minisequencing. Biotechniques 1994;16:938–43.
   Google Scholar
• Syvänen A-C. Detection of point mutations in human genes by the solid-phase minisequencing method. Clin Chim Acta 1994; 226:225–36.
   PubMed Web of Science ®Google Scholar
• Dhillon AP, Anthony A, Sim R, Wakefield AJ, Sankey EA, Hudson M, et al. Mucosal capillary thrombi in rectal biopsies. Histopathology 1992;21:127–33.
   PubMed Web of Science ®Google Scholar
• Wakefield AJ, Sawyerr AM, Dhillon AP, Pittilo RM, Rowles PM, Lewis AAM, et al. Pathogenesis of Crohn’s disease: multifocal gastrointestinal infarction. Lancet 1989;2:1057–62.
   PubMed Web of Science ®Google Scholar
• Sankey EA, Dhillon AP, Anthony A, Wakefield AJ, Sim R, More L, et al. Early mucosal changes in Crohn’s disease. Gut 1993;34:375–81.
   PubMed Web of Science ®Google Scholar
• Gaffney PR, Doyle CT, Gaffney A, Hogan J, Hayes DP, Annis P. Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol 1995;90:220–3.
   PubMed Web of Science ®Google Scholar
• Thompson NP, Wakefield AJ, Pounder RE. Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology 1995;108:1011–5.
   Google Scholar
• Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral- contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994;344:1453–7.
   PubMed Web of Science ®Google Scholar
• Halbmayer W-M, Haushofer A, Schon R, Fischer M. The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood Coagul Fibrinol 1994;5:51–7.
   Google Scholar
• Cushman M, Bhushan F, Bovill E, Tracy R. Plasma resistance to activated protein C in venous and arterial thrombosis. Thromb Haemost 1994;72:647.
   PubMed Web of Science ®Google Scholar
• Kontula K, Ylikorkala A, Miettinen H, Vuorio A, Kauppinen-Mäkelin R, Hämäläinen L, et al. Arg506Gln factor V mutation (Factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost 1995;73: 558–60.
   Google Scholar
• Forsyth PDG. Activated protein C resistance in cases of cerebral infarction. Lancet 1995;345:795.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995;332:912–7.
   PubMed Web of Science ®Google Scholar
• Samani NJ, Lodwick D, Martin D, Kimber P. Resistance to activated protein C and risk of premature myocardial infarction. Lancet 1994;344:1709–10.
   PubMed Web of Science ®Google Scholar
• Emmerich J, Poirier O, Evans A, Marques-Vidal P, Arveiler D, Luc G, et al. Myocardial infarction, Arg 506 to Gln factor V mutation, and activated protein C resistance. Lancet 1995;345: 321.
   Google Scholar
• Probert CSJ, Haslam S, Aslam S, Standen G. Is Factor V Leiden associated with inflammatory bowel disease? Gut 1997;41 Suppl 3.
   Google Scholar